Sort   by:  
 Page size 
UnknownSoy Isoflavones Accelerate Glial Cell Migration via GPER-Mediated Signal Transduction Pathway.
Not available
S-EPMC7672195 | biostudies-literature
UnknownGain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma.
Not available
S-EPMC7827173 | biostudies-literature
UnknownCD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia.
Not available
S-EPMC8149417 | biostudies-literature
UnknownSteroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer.
Not available
S-EPMC7854521 | biostudies-literature
UnknownInvestigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
Not available
S-EPMC10864576 | biostudies-literature
TranscriptomicsBaseline and Post-Bortezomib gene expression profiling of CD138 purified bone marrow plasma cells from multiple myeloma patients
High PSMD4 expression levels in plasma cells are linked to poor prognosis in multiple myeloma. Additional file available-E-TABM-1138.additional.zip
ORGANISM(S): Homo sapiens 
2012-03-31 | E-TABM-1138 | biostudies-arrayexpress
UnknownSynergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
Not available
S-EPMC8509545 | biostudies-literature
UnknownThe Impact of Immune-Related Adverse Event Severity on Prognosis in Elderly Patients With Nonsmall-Cell Lung Cancer in First-Line Immune Checkpoint Inhibitor Treatment.
Not available
S-EPMC11790473 | biostudies-literature
UnknownAcquired resistance to everolimus in aromatase inhibitor-resistant breast cancer.
Not available
S-EPMC5940386 | biostudies-literature
UnknownPrimary Bladder Lymphoma with Extravesical Extension: A Case Report and Literature Review on Prognosis and Clinical Characteristics.
Not available
S-EPMC11313225 | biostudies-literature
Sort   by:  
 Page size